Saturday 26 June 2010

Diclofenac dietilamino




Diclofenac dietilamino may be available in the countries listed below.


Ingredient matches for Diclofenac dietilamino



Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Diclofenac dietilamino in the following countries:


  • Venezuela

International Drug Name Search

Saturday 19 June 2010

S.E.Z. Drinking Water Solution




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for S.E.Z. Drinking Water Solution



Sulfaethoxypyridazine

Sulfaethoxypyridazine is reported as an ingredient of S.E.Z. Drinking Water Solution in the following countries:


  • United States

International Drug Name Search

Wednesday 16 June 2010

Dexrazoxane Hydrochloride




Ingredient matches for Dexrazoxane Hydrochloride



Dexrazoxane

Dexrazoxane Hydrochloride (BANM) is known as Dexrazoxane in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 15 June 2010

Urotan




Urotan may be available in the countries listed below.


Ingredient matches for Urotan



Nalidixic Acid

Nalidixic Acid is reported as an ingredient of Urotan in the following countries:


  • Peru

International Drug Name Search

Friday 11 June 2010

Opetarl




Opetarl may be available in the countries listed below.


Ingredient matches for Opetarl



Cilostazol

Cilostazol is reported as an ingredient of Opetarl in the following countries:


  • Japan

International Drug Name Search

Sunday 6 June 2010

betaine


BEE-ta-een


Commonly used brand name(s)

In the U.S.


  • Cystadane

Available Dosage Forms:


  • Powder for Suspension

  • Tablet

Therapeutic Class: Digestant


Uses For betaine


Betaine is used to treat a lack of or defect in certain enzymes that causes too much homocysteine in the blood and urine. betaine removes the extra homocysteine from the body.


betaine is available only with your doctor's prescription.


Before Using betaine


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For betaine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to betaine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


betaine has been tested in children and, in effective doses, has not been shown to cause different side effects or problems than it does in adults. However, children may require more frequent changes in their dose than adults.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing the use of betaine in the elderly with use in other age groups.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Proper Use of betaine


Betaine powder should be mixed with 4 to 6 ounces of juice, milk, or water until completely dissolved. The solution should be used immediately after mixing.


Do not use if the powder does not dissolve completely or gives a colored solution.


Betaine should be taken with meals.


It is important that you follow any special instructions from your doctor, such as taking folic acid, pyridoxine (vitamin B 6), and vitamin B 12 supplements. If you have any questions about this, check with your doctor.


Dosing


The dose of betaine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of betaine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (powder for solution):
    • To prevent buildup of homocysteine:
      • Adults, teenagers, and children 3 years of age and older—The starting dose is usually 3 grams taken two times a day with meals. Your doctor may adjust your dose as needed.

      • Children younger than 3 years of age—The dose is based on body weight and must be determined by your doctor. Betaine should be taken with meals.



Missed Dose


If you miss a dose of betaine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using betaine


Your doctor should check your progress at regular visits to make sure that betaine is working properly.


betaine Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Diarrhea

  • nausea

  • stomach upset

Betaine may cause a body odor. Other side effects not listed above may also occur in some patients. If you notice any other effects, check with your doctor.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More betaine resources


  • Betaine Side Effects (in more detail)
  • Betaine Use in Pregnancy & Breastfeeding
  • Betaine Support Group
  • 0 Reviews for Betaine - Add your own review/rating


  • betaine Concise Consumer Information (Cerner Multum)

  • Betaine Powder MedFacts Consumer Leaflet (Wolters Kluwer)

  • Cystadane Prescribing Information (FDA)



Compare betaine with other medications


  • Nonalcoholic Fatty Liver Disease

Friday 4 June 2010

Sutent


Sutent is a brand name of sunitinib, approved by the FDA in the following formulation(s):


SUTENT (sunitinib malate - capsule; oral)



  • Manufacturer: CPPI CV

    Approval date: January 26, 2006

    Strength(s): EQ 12.5MG BASE, EQ 25MG BASE, EQ 50MG BASE [RLD]


  • Manufacturer: CPPI CV

    Approval date: March 31, 2009

    Strength(s): EQ 37.5MG BASE

Has a generic version of Sutent been approved?


No. There is currently no therapeutically equivalent version of Sutent available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sutent. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pyrrole substituted 2-indolinone protein kinase inhibitors
    Patent 6,573,293
    Issued: June 3, 2003
    Inventor(s): Peng Cho; Tang & Todd A.; Miller & Xiaoyuan; Li & Li; Sun & Chung Chen; Wei & Shahrzad; Shirazian & Congxin; Liang & Tomas; Vojkovsky & Asaad S.; Nematalla & Michael; Hawley
    Assignee(s): Sugen, Inc.
    Pharmacia & Upjohn Co.
    The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Patent expiration dates:

    • February 15, 2021
      ✓ 
      Patent use: TREATMENT OF PROTEIN KINASE RELATED DISORDERS, SUCH AS GASTROINTESTINAL STROMAL TUMORS, RENAL CELL CARCINOMA AND ADVANCED PANCREATIC NEUROENDOCRINE TUMORS, WITH SUNITINIB
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Pyrrole substituted 2-indolinone protein kinase inhibitors
    Patent 7,125,905
    Issued: October 24, 2006
    Inventor(s): Tang; Peng Cho & Miller; Todd A. & Li; Xiaoyuan & Sun; Li & Wei; Chung Chen & Shirazian; Shahrzad & Liang; Congxin & Vojkovsky; Tomas & Nematalla; Asaad S. & Hawley; Michael
    Assignee(s): Agouron Pharmaceuticals, Inc.
    The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Patent expiration dates:

    • February 15, 2021
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
    Patent 7,211,600
    Issued: May 1, 2007
    Inventor(s): Lipson; Ken & McMahon; Gerald
    Assignee(s): Sugen Inc.
    The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity c-kit kinase.
    Patent expiration dates:

    • December 22, 2020
      ✓ 
      Patent use: TREATMENT OF GASTROINTESTINAL STROMAL TUMOR WITH SUNITINIB



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • January 26, 2011 - NEW CHEMICAL ENTITY

    • May 20, 2014 - TREATMENT OF PROGRESSIVE, WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMORS IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC DISEASE

See also...

  • Sutent Consumer Information (Wolters Kluwer)
  • Sutent Consumer Information (Cerner Multum)
  • Sutent Advanced Consumer Information (Micromedex)
  • Sutent AHFS DI Monographs (ASHP)
  • Sunitinib Consumer Information (Wolters Kluwer)
  • Sunitinib Consumer Information (Cerner Multum)
  • Sunitinib Advanced Consumer Information (Micromedex)
  • Sunitinib malate Advanced Consumer Information (Micromedex)
  • Sunitinib Malate AHFS DI Monographs (ASHP)